Regulating Digital Pharmacies in Malaysia: Lessons from the United States

Authors

  • Ibtisam @ Ilyana Ilias Faculty of Law, Universiti Teknologi MARA, Malaysia
  • Raudhoh Shaari Pharmacy Enforcement Division, Kedah State Health Department, Ministry of Health, Malaysia
  • Hetty Hassanah Faculty of Law, Universitas Komputer, Indonesia
  • Mohd Kamal Ilias Emir Mahmud & Co, Malaysia

DOI:

https://doi.org/10.21834/e-bpj.v11i36.7813

Keywords:

E-commerce, Pharmaceutical products, Online platform liability, Digital health regulation

Abstract

E-commerce has experienced rapid growth, and access to pharmaceutical products has changed, raising questions about unauthorised online sales and platform responsibility. Malaysia lacks comprehensive pharmaceutical legislation for digital intermediaries. By comparison, the United States takes a complex regulatory approach that includes federal drug regulations and market-based transparency requirements. This study employs doctrinal and comparative approaches to assess the adequacy of Malaysia's regulatory framework. The findings highlight fragmented enforcement and weak platform responsibilities, underscoring the need for reforms to improve verification, traceability, and consumer protection.  

References

Aditya Maulana Rizqi, & Muhammad Ramli. (2024). E-Commerce Liability to Consumers For the Sale of Black Market Products. AL-MIKRAJ Jurnal Studi Islam Dan Humaniora (E-ISSN 2745-4584), 5(01), 482–494. https://doi.org/10.37680/almikraj.v5i01.5867 DOI: https://doi.org/10.37680/almikraj.v5i01.5867

Ahmed, J., Modica de Mohac, L., Mackey, T. K., & Raimi-Abraham, B. T. (2022). A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives. The Journal of Medicine Access, 6. https://doi.org/10.1177/23992026221074548 DOI: https://doi.org/10.1177/23992026221074548

Alphonsoes, A. A., Zain, F. M., Velisamy, M. V., Pilus, M., Ali, N. A., & Suleiman, N. (2021). patterns-of-prescription-medicines-sale-through-e-marketplace-in-malaysia-and-associating-factors. Malaysian Journal of Pharmacy, 7(2), 85–97. https://doi.org/10.52494/qaic7337 DOI: https://doi.org/10.52494/QAIC7337

Brannon, V. C., & Holmes, E. N. (2024, January 4). Section 230: An Overview. Congress.gov. https://www.congress.gov/crs-product/R46751

Fairgrieve, D., Busch, C., Erdem Büyüksagis, Garrett, Z. G., Gert Straetmans, Antonios Karaiskos, Linley, R. D., Markou, C., Paterson, J. M., & Sharkey, C. M. (2024). PRODUCT LIABILITY AND ONLINE MARKETPLACES: COMPARISON AND REFORM. International and Comparative Law Quarterly, 1–28. https://doi.org/10.1017/s0020589324000046 DOI: https://doi.org/10.1017/S0020589324000046

Hutchinson, T., & Duncan, N. (2012). Defining and describing what we do: Doctrinal legal research. Deakin Law Review, 17(1), 83–119. DOI: https://doi.org/10.21153/dlr2012vol17no1art70

INTERPOL. (2025, June 25). Record 769 arrests and USD 65 million in illicit pharmaceuticals seized in global bust. Interpol.int. https://www.interpol.int/en/News-and-Events/News/2025/Record-769-arrests-and-USD-65-million-in-illicit-pharmaceuticals-seized-in-global-bust

Liang, B. A., & MacKey, T. (2009). Searching for Safety: Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales. American Journal of Law & Medicine, 35(1), 125–184. https://doi.org/10.1177/009885880903500104 DOI: https://doi.org/10.1177/009885880903500104

Lim, L. P., & Abdul Aziz, M. F. (2025). The issues and challenges of addressing the importation of unregistered pharmaceutical products in Malaysia. PubMed, 18(1), 2523939–2523939. https://doi.org/10.1080/20523211.2025.2523939 DOI: https://doi.org/10.1080/20523211.2025.2523939

Lim, P., & Yang, C. (2025, June 26). Malaysia seizes US$1.6m in illegal health products during global Interpol crackdown. CNA. https://www.channelnewsasia.com/asia/malaysia-illegal-pharmaceuticals-global-operation-interpol-health-products-5204826

Mackey, T. K., & Liang, B. A. (2013). Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Globalization and Health, 9(1), 45. https://doi.org/10.1186/1744-8603-9-45 DOI: https://doi.org/10.1186/1744-8603-9-45

Mackey, T. K., & Nayyar, G. (2016). Digital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies. British Medical Bulletin, 118(1), 110–126. https://doi.org/10.1093/bmb/ldw016 DOI: https://doi.org/10.1093/bmb/ldw016

Times, N. S. (2023, March 16). 70.6pct of Malaysians used e-commerce for purchases in 2023. NST Online; New Straits Times. https://www.nst.com.my/news/nation/2025/03/1188966/706pct-malaysians-used-e-commerce-purchases-2023.

United Nations. (2025). Peace, justice and strong institutions. United Nations Sustainable Development; United Nations. https://www.un.org/sustainabledevelopment/peace-justice/

World Health Organisation. (2026). SF Medical Products – The Internet. Who.int. https://www.who.int/teams/regulation-prequalification/incidents-and-SF/background/sf-medical-products-the-internet

Zuryani, Z., Zakuan, M., & Ismail, R. (2021). Illegal Medical Product and Consumer Protection in Malaysia. International Journal of Law, Government and Communication, 6(25), 1-08. https://doi.org/10.35631/IJLGC.625001 DOI: https://doi.org/10.35631//IJLGC.625001

Downloads

Published

2026-04-11

How to Cite

Ilias, I. @ I., Shaari, R., Hassanah, H., & Ilias, M. K. (2026). Regulating Digital Pharmacies in Malaysia: Lessons from the United States. Environment-Behaviour Proceedings Journal, 11(36), 67–72. https://doi.org/10.21834/e-bpj.v11i36.7813